AstraZeneca has reversed course and pledged to provide Zoladex — a life-saving drug for breast cancer and endometriosis patients — free of charge indefinitely, after facing massive public backlash. The drug, which halts estrogen production to prevent disease progression, was initially pulled from Australia’s public and private markets, forcing some women to consider drastic surgeries like oophorectomy. Fueled by a 42,000-signature petition and relentless advocacy, the company expanded its free access program from six months to permanent, ensuring thousands of patients won’t lose critical treatment. This moment underscores the power of patient voices and public pressure in shaping pharmaceutical policy, while also spotlighting broader debates over drug pricing and access in Australia.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
